China Continuous Glucose Monitoring Devices Market Size
| Study Period | 2018-2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 505.13 Million |
| Market Size (2029) | USD 828.10 Million |
| CAGR (2024 - 2029) | 10.39 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
China Continuous Glucose Monitoring Devices Market Analysis
The China Continuous Glucose Monitoring Devices Market size is estimated at USD 505.13 million in 2024, and is expected to reach USD 828.10 million by 2029, growing at a CAGR of 10.39% during the forecast period (2024-2029).
Maintaining good glycemic control during the COVID-19 pandemic was paramount to patients with diabetes mellitus. The deterioration of glycemic control led to chronic complications of diabetes mellitus and increased the risk of infection and associated mortality. Moreover, COVID-19 patients with uncontrolled type-2 diabetes had markedly higher mortality rates than those with good glycemic control. In addition, a few lab studies also suggested that the coronavirus had preferentially infected the insulin-producing beta cells. The SARS-CoV-2 infection led to reduced production and release of insulin from pancreatic islet tissue due to the death of some of the important beta cells, which led to diabetes in some people after suffering from acute COVID-19 infection. Thereby increasing the demand for continuous glucose monitoring devices to monitor and maintain optimum blood glucose levels.
Glucose monitoring increases patients’ awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values help in providing feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely Monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and incorporate additional relevant data, such as insulin doses, meals/snacks, and physical activity, can further support self-management while decreasing disease burden and benefitting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, thereby enhancing the market prospects in the years to come.
China Continuous Glucose Monitoring Devices Market Trends
Rising Diabetes Prevalence in China
The diabetes population in China is expected to grow by about 1.05% over the forecast period.
According to IDF Diabetes Atlas's latest estimates, an estimated 141 million adults were living with diabetes in China, which is a rise of 20% over the past two years. It has the highest number of deaths from diabetes in the Western Pacific region, at approximately 1.4 million, and the second-highest diabetes-related health expenditure in the world. More than half of adults currently living with diabetes in China are undiagnosed.
China has the world’s largest population of people with diabetes, which continues to grow with the country’s rapid urbanization. Chinese Ministry of Health has established a network of National Demonstration Areas to develop pilot projects for health promotion, detection, and control of chronic diseases. Various local government departments with country officials are responsible for overall coordination. Primary care providers promote education and self-management of health conditions through appropriate dietary changes, control of tobacco use, and physical activity, which are beneficial for diabetes control.
Continuous glucose monitoring is essential to manage highly diabetic patients. The blood glucose levels help the patients and doctors modify their diet, lifestyle, insulin therapy, and medications to help their blood sugar return to normal. With newer innovations in medical technology, CGMs these days have highly sensitive sensors that can detect every component of blood accurately close to lab results.
As a long-term strategy, China is extending efforts at health promotion, detection, and control of diabetes with academic medical centers (AMCs) and hospitals with effective primary care. AMCs are usually overcrowded with patients with simple conditions, while the primary care system is under-equipped with basic medical infrastructure and an under-qualified workforce. The State Council has encouraged health system integration by promoting a hierarchical medical system, a policy that attempts to attract more patients to primary health centers before going to AMCs.
Therefore, owing to the increasing diabetes prevalence the studied market is anticipated to witness growth over the analysis period.
The Sensors Segment holds the highest market share in the current year
The sensors segment holds the highest market share in the current year and is expected to grow at a CAGR of 12.04% over the forecast period.
Continuous glucose monitoring sensors use glucose oxidase to detect blood sugar levels. Glucose oxidase converts glucose to hydrogen peroxidase, which reacts with the platinum inside the sensor, producing an electrical signal to be communicated to the transmitter. Sensors are the most important part of continuous glucose monitoring. Technological advancements to improve the accuracy of the sensors are expected to drive segment growth during the forecast period.
Researchers are trying to explore alternatives to electrochemical-based glucose sensors and create more affordable, minimally invasive, and user-friendly CGM sensors. Optical measurement is a promising platform for glucose sensing. Some technologies have been reported to have high potential in continuous glucose sensing, including spectroscopy, fluorescence, holographic technology, etc. Eversense, a CGM sensor based on fluorescence sensing developed by Senseonics Company, presents a much longer lifespan in comparison with electrochemical sensors.
The Healthy China 2030 Plan, approved by the State Council and the Party’s Central Committee, puts diabetes, along with cancer, hypertension, and cardiovascular diseases, in the four major non-communicable diseases to “control the prevalence and reduce the probability of early death.” The central government launched a 2017-2025 plan to control non-communicable diseases, which includes increasing the regular monitoring and self-management rate for diabetes patients from 50% to 70% by 2025. Such factors are expected to boost market growth.
China Continuous Glucose Monitoring Devices Industry Overview
The Chinese continuous glucose monitoring devices market is consolidated, with few significant players. There have been constant innovations driven by manufacturers such as Abbott, Dexcom, Medtronic, etc. while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.
China Continuous Glucose Monitoring Devices Market Leaders
-
Abbott
-
Medtronic
-
Dexcom
-
Ascensia
-
Sibionics
*Disclaimer: Major Players sorted in no particular order
China Continuous Glucose Monitoring Devices Market News
- November 2023: SIBIONICS, a Chinese company, announced that it received the CE Mark for its revolutionary GS1 CGM. This significant milestone marks a momentous achievement for SIBIONICS, facilitating the distribution and utilization of this game-changing technology throughout the European market.
- June 2023: Medical diagnostic company Know Labs is aiming to release the world’s first commercially available non-invasive glucose monitor with the launch of its Generation (Gen) 1 device. The device houses the company’s Bio-RFID technology, which was shown to consistently and accurately measure glucose levels non-invasively in a feasibility study conducted by the Washington, US-based company across late 2022 and early 2023.
China Continuous Glucose Monitoring Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.3 Market Restraints
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Component
- 5.1.1 Sensors
- 5.1.2 Durables
6. MARKET INDICATORS
- 6.1 Type-1 Diabetes Population
- 6.2 Type-2 Diabetes Population
7. COMPETITIVE LANDSCAPE
-
7.1 Company Profiles
- 7.1.1 Abbott Diabetes Care
- 7.1.2 Dexcom Inc.
- 7.1.3 Medtronic PLC
- 7.1.4 Ascensia Diabetes Care
- 7.1.5 GlySens
- 7.1.6 Yuwell
- 7.1.7 Jiunuo Medical
- *List Not Exhaustive
-
7.2 Company Share Analysis
- 7.2.1 Abbott Diabetes Care
- 7.2.2 Dexcom Inc.
- 7.2.3 Medtronic PLC
- 7.2.4 Other Company Share Analyses
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityChina Continuous Glucose Monitoring Devices Industry Segmentation
Continuous glucose monitoring devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients throughout the day. The Chinese continuous glucose monitoring device market is segmented into components (sensors and durables).
The report offers the value (in USD) and volume (in units) for the above segments.
| Component | Sensors |
| Durables |
China Continuous Glucose Monitoring Devices Market Research FAQs
How big is the China Continuous Glucose Monitoring Devices Market?
The China Continuous Glucose Monitoring Devices Market size is expected to reach USD 505.13 million in 2024 and grow at a CAGR of 10.39% to reach USD 828.10 million by 2029.
What is the current China Continuous Glucose Monitoring Devices Market size?
In 2024, the China Continuous Glucose Monitoring Devices Market size is expected to reach USD 505.13 million.
Who are the key players in China Continuous Glucose Monitoring Devices Market?
Abbott, Medtronic, Dexcom, Ascensia and Sibionics are the major companies operating in the China Continuous Glucose Monitoring Devices Market.
What years does this China Continuous Glucose Monitoring Devices Market cover, and what was the market size in 2023?
In 2023, the China Continuous Glucose Monitoring Devices Market size was estimated at USD 452.65 million. The report covers the China Continuous Glucose Monitoring Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the China Continuous Glucose Monitoring Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
China Continuous Glucose Monitoring Devices Industry Report
Statistics for the 2024 China Continuous Glucose Monitoring Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Continuous Glucose Monitoring Devices analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
